Navigation Links
Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
Date:8/14/2013

LONDON, August 14, 2013 /PRNewswire/ --

The U.S. equity market ended higher on Tuesday, August 13, 2013, after finishing on a mixed note in the previous trading session. The S&P 500 rose 0.28% to close at 1,694.16. The biotechnology companies ended mostly lower, even as the broader market edged higher. The major movers in the sector included BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), PDL BioPharma Inc. (NASDAQ: PDLI), and Amgen Inc. (NASDAQ: AMGN). AAAResearchReports.com has released full comprehensive research on BCRX, QCOR, PDLI, and AMGN. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/  

Shares in BioCryst Pharmaceuticals Inc. fell sharply on Tuesday, even as the broader market posted gains. The company's shares closed the day 2.31% lower at $5.50 after oscillating between $5.43 and $5.71. A total of 1.32 million shares were traded which is below the daily average volume of 3.54 million. BioCryst Pharmaceuticals Inc.'s shares have gained 203.87% in the last three months, as compared to a gain of 3.70% in the S&P 500 during the same period. Moreover, the company's shares are trading above their 50-day and 200-day moving averages. Download free report on BCRX upon registration at:

http://www.AAAResearchReports.com/BCRX081413.pdf

Shares in Questcor Pharmaceuticals Inc. surged on Tuesday, tracking gains in the broader market. The company's shares oscillated between $66.25 and $69.33 before finishing the day 4.40% higher at $69.05. A total of 1.93 million shares were traded which is marginally above the daily average volume of 1.92 million. Questcor Pharmaceuticals' shares have gained 40.06% in the last one month and 84.13% in the last three months, outperforming the S&P 500 which has gained 0.83% and 3.70% in the respective periods. Moreover, the stock is currently trading near its 52-week high of $70.55. QCOR technical report can be accessed for free by signing up at:

http://www.AAAResearchReports.com/QCOR081413.pdf

PDL BioPharma Inc.'s shares fluctuated between $8.34 and $8.45 on Tuesday before ending the day 0.36% lower at $8.41. A total of 1.67 million shares were traded which is below the daily average volume of 1.84 million. The company's shares have gained 3.44% during the last three trading sessions, and 3.70% in the last three months. Despite Tuesday's pullback, the stock is trading near its 52-week high of $8.48, and also above its 50-day and 200-day moving averages. The free report on PDLI can be downloaded by signing up now at:

http://www.AAAResearchReports.com/PDLI081413.pdf

Amgen Inc.'s stock ended slightly lower on Tuesday, finishing at $107.86, down 0.32% from its previous closing price. The company's shares oscillated between $107.03 and $108.92. A total of 2.68 million shares were traded which is below the daily average volume of 3.22 million. The stock has gained 3.44% in the last one month, outperforming the S&P 500 which has gained 0.83% during the same period. Additionally, the stock is trading above its 50-day and 200-day moving averages. A free report on AMGN can be accessed by registering at:

http://www.AAAResearchReports.com/AMGN081413.pdf

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA ® charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.



'/>"/>
SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical
2. "Good in the Morning" is the Tastiest Summer Single by Mike Brumm of Milwaukee, WI
3. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
4. More than Morning Sickness: Kate Middletons Pregnancy Announcement Draws Attention to Rare Pregnancy Condition Known as Hyperemesis Gravidarum (HG)
5. Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
6. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
7. Todays Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn
8. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
9. New Research: Nationwide Report Shows Prescribed Drugs Not Detected in More Than One-Third of Pain Patient Samples
10. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
11. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Ambulances announces its first delivery in the state of ... Emergency Medical Services (EMS) consisting of four vehicles: three ... Emergency Vehicles in Lecanto, FL , USA, ... the latest in Demers, ongoing expansion of sales.  ... --> Benoit LaFortune , Executive Vice President at Demers. ...
(Date:2/12/2016)...  Memorial Hermann Health System has teamed up with ... bring a one-of-a-kind experience to pediatric patients at ... as 360-degree video and Google Cardboard, Howard was able ... giving the patients and their families an unexpected, and ... on video . Memorial Hermann IRONMAN ...
(Date:2/12/2016)... Ontario , Feb. 12, 2016  Aralez Pharmaceuticals ... pharmaceutical company, today announced the Company will ring the Nasdaq ... New York at 4:00 p.m. ... formation of Aralez. Adrian Adams , ... be held 3:50 to 4:00 p.m. ET.  A live ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... For Coast Dental dentist Everet Lake, ... and dental assistant Terrell Moore shortly before 7 a.m. to volunteer at Friday’s Dentistry ... donating their time and skills to help hundreds of uninsured and underinsured people receive ...
(Date:2/12/2016)... ... February 12, 2016 , ... Nearly every health website ... health. These articles generally list between five and 15 foods that should be ... every one of these lists and believes that nutritious eye healthy foods are ...
(Date:2/12/2016)... ... February 12, 2016 , ... US Sport Camps is pleased to announce ... located in Norwalk, serves as the host site and directing the camps is PGA ... have had successful camps in recent years around Des Moines and are fortunate to ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Central Coast Autism Spectrum Center (CCASC) invites teens ... provide a night of fun for teens with and without special needs to gather in ... included at the event. The dance will take place on Saturday, Feb. 13 from 7 ...
(Date:2/12/2016)... Mi (PRWEB) , ... February 12, 2016 , ... Basketball ... unique and integral part of the Peety PoppersTM series, sign language translation is featured ... message of health and wellness in Peety PoppersTM lessons has a sign language translator ...
Breaking Medicine News(10 mins):